Clinical Trial

tACS to Improve Negative Symptoms & Cognition in Long-term Hospitalized Schizophrenia Patients.

Enrolling by Invitation
View on ClinicalTrials.gov →
Record status
This record was last updated July 24, 2025 (before its estimated February 5, 2026 completion). Its status may not reflect the trial's current state.
Summary
This study aims to evaluate the efficacy of transcranial alternating current stimulation (tACS) on negative symptoms and cognitive function in long-term hospitalized patients with schizophrenia. At the same time, this study will explore the potential impact of relevant biomarkers and genetic factors on the efficacy of tACS intervention.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-07-10.
Trial Details
NCT Number NCT07074704
Lead Sponsor Tongji University
Conditions Negative Symptoms in Schizophrenia, Cognition Function
Enrollment 60 participants
Start Date 2025-06-11
Primary Completion 2026-02-05 (estimated)
Study Completion 2026-06-05 (estimated)
Updated on ClinicalTrials.gov 2025-07-24